Regeneron Pharmaceuticals Up Nearly 7%, on Track for Record High Close -- Data Talk
March 23 2023 - 12:18PM
Dow Jones News
Regeneron Pharmaceuticals, Inc. (REGN) is currently at $802.50,
up $51.20 or 6.81%
--Would be new all-time high (Based on available data back to
April 2, 1991)
--On pace for largest percent increase since Sept. 8, 2022, when
it rose 18.85%
--Currently up three of the past four days
--Up 5.53% month-to-date; on pace for best month since Oct.
2022, when it rose 8.69%
--Up 11.23% year-to-date
--Up 18.06% from 52 weeks ago (March 24, 2022), when it closed
at $679.76
--Would be a new 52-week closing high
--Up 46.35% from its 52-week closing low of $548.35 on June 14,
2022
--Traded as high as $812.69; new all-time intraday high (Based
on available data back to April 2, 1991)
--Up 8.17% at today's intraday high; largest intraday percent
increase since Sept. 8, 2022, when it rose as much as 20.54%
--Third best performer in the S&P 500 today
--Second best performer in the Nasdaq 100 today
All data as of 11:45:27 AM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
March 23, 2023 12:03 ET (16:03 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
Regeneron Pharmaceuticals (NASDAQ:REGN)
Historical Stock Chart
From Apr 2023 to May 2023
Regeneron Pharmaceuticals (NASDAQ:REGN)
Historical Stock Chart
From May 2022 to May 2023